Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytomegalovirus, adenovirus, and polyomavirus co-infection among pediatric recipients of allogeneic stem cell transplantation: characteristics and outcome.
Watcharananan SP, Kiertiburanakul S, Piyatuctsanawong W, Anurathapan U, Sungkanuparph S, Pakakasama S, Chantratita W, Hongeng S. Watcharananan SP, et al. Among authors: anurathapan u. Pediatr Transplant. 2010 Aug;14(5):675-81. doi: 10.1111/j.1399-3046.2010.01325.x. Epub 2010 Apr 13. Pediatr Transplant. 2010. PMID: 20412509
Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease control.
Anurathapan U, Pakakasama S, Rujkijyanont P, Sirachainan N, Songdej D, Chuansumrit A, Sirireung S, Charoenkwan P, Jetsrisuparb A, Issaragrisil S, Ungkanont A, Sruamsiri R, Srisala S, Andersson BS, Hongeng S. Anurathapan U, et al. Biol Blood Marrow Transplant. 2013 Aug;19(8):1259-62. doi: 10.1016/j.bbmt.2013.04.023. Epub 2013 May 3. Biol Blood Marrow Transplant. 2013. PMID: 23648235 Free PMC article. Clinical Trial.
Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratification.
Anurathapan U, Pakakasama S, Mekjaruskul P, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Pongtanakul B, Rujkijyanont P, Meekaewkunchorn A, Sruamsiri R, Ungkanont A, Issaragrisil S, Andersson BS, Hongeng S. Anurathapan U, et al. Biol Blood Marrow Transplant. 2014 Dec;20(12):2066-71. doi: 10.1016/j.bbmt.2014.07.016. Epub 2014 Jul 23. Biol Blood Marrow Transplant. 2014. PMID: 25064743 Free PMC article.
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Choeyprasert W, Pakakasama S, Sirachainan N, Songdej D, Chuansumrit A, Anurathapan U, Hongeng S, Nartthanarung A. Choeyprasert W, et al. Among authors: anurathapan u. Asian Pac J Cancer Prev. 2014;15(22):9823-9. doi: 10.7314/apjcp.2014.15.22.9823. Asian Pac J Cancer Prev. 2014. PMID: 25520112 Free article. Clinical Trial.
101 results